Drug intelligence / Profile preview

Castellani paint

Development stage: Unknown
Lead developer: Stratus Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

Castellani paint is a topical anti-infective solution traditionally composed of phenol, resorcinol, boric acid, acetone, and basic fuchsin. It is primarily used for the treatment of fungal skin infections, such as tinea pedis (athlete's foot) and tinea cruris (jock itch), as well as bacterial infections like erythrasma. The solution acts as an antiseptic, disinfectant, and antifungal agent. The "modified" version typically excludes basic fuchsin to avoid staining. Stratus Pharmaceuticals is a key developer and manufacturer of this product, which has been a staple in dermatological practice for decades due to its broad-spectrum antimicrobial properties.

Brand names: Castellani Paint
Other names: Carbol-Fuchsin SolutionCastellani's Solution

Beyond the preview

Go deeper on Castellani paint.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Castellani paint.

Explore the full profile